Universe Pharmaceuticals INC (UPC): Price and Financial Metrics


Universe Pharmaceuticals INC (UPC): $0.92

-0.11 (-10.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add UPC to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

UPC Stock Price Chart Interactive Chart >

Price chart for UPC

UPC Price/Volume Stats

Current price $0.92 52-week high $5.00
Prev. close $1.03 52-week low $0.90
Day low $0.90 Volume 180,400
Day high $1.03 Avg. volume 55,906
50-day MA $1.18 Dividend yield N/A
200-day MA $1.75 Market Cap 20.01M

Universe Pharmaceuticals INC (UPC) Company Bio


Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Jiangxi, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.


UPC Latest News Stream


Event/Time News Detail
Loading, please wait...

UPC Latest Social Stream


Loading social stream, please wait...

View Full UPC Social Stream

Latest UPC News From Around the Web

Below are the latest news stories about Universe Pharmaceuticals INC that investors may wish to consider to help them evaluate UPC as an investment opportunity.

Universe Pharmaceuticals INC's (NASDAQ:UPC) Earnings Are Not Doing Enough For Some Investors

Universe Pharmaceuticals INC's ( NASDAQ:UPC ) price-to-earnings (or "P/E") ratio of 2.8x might make it look like a...

Yahoo | February 9, 2022

Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial Results

Ji’an, Jiangxi, China, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2021. Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented, “We are excited to share our financial results for the fiscal year 2021, and flattered to see that we have achieved significant growth in financial results. Although we enc

Yahoo | January 31, 2022

Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine

Ji’an, Jiangxi, China, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into two strategic cooperation agreements (the “Agreements”) with Jiangxi Province Institute of Materia Medica (“Jiangxi IMM”), an inspection and testing institution fully funded by the Jiangxi Province Medical Products Administration, which promotes the development of the pharmaceutic

Yahoo | January 4, 2022

Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

Ji’an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Jinggangshan University (“JGSU”), a public university located in Ji'an City of Jiangxi Province, for a study on the chemical constituents of Liparis Odorata, a traditional Chinese medicine, for the treatment of hyperlipidemi

Yahoo | December 29, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, trader!

William White on InvestorPlace | December 21, 2021

Read More 'UPC' Stories Here

UPC Price Returns

1-mo -22.70%
3-mo -25.20%
6-mo -57.41%
1-year -71.34%
3-year N/A
5-year N/A
YTD -43.73%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6217 seconds.